GRCE
Grace Therapeutics
GRCE
GRCE
20 hedge funds and large institutions have $11M invested in Grace Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $11.3M → $11M (-$311K)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$517K | |
| 2 | +$169K | |
| 3 | +$42K | |
| 4 |
Citigroup
New York
|
+$8.19K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$771 |
Top Sellers
| 1 | -$658K | |
| 2 | -$243K | |
| 3 | -$144K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$21.1K |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
-$86 |
